Transcriptional co-activator p300 maintains basal hepatic gluconeogenesis

J Biol Chem. 2012 Sep 14;287(38):32069-77. doi: 10.1074/jbc.M112.385864. Epub 2012 Jul 19.

Abstract

A major cause of fasting hyperglycemia in diabetes mellitus is unregulated hepatic glucose production (HGP). Insulin suppresses HGP by phosphorylating CBP and disassembling the CREB-CBP complex from gluconeogenic genes. p300 is closely related to CBP; but in contrast to CBP, p300 binds constitutively to CREB due to the absence of phosphorylation site found in CBP. In a phosphorylation-competent p300(G442S) knock-in mouse model, we demonstrate that HGP is now exquisitely sensitive to insulin suppression. p300(G422S) and hepatic-deleted p300 mice exhibited significant lower blood glucose levels in the fasted and post-prandial states, indicating a role for p300 in maintaining basal HGP.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cell Line, Tumor
  • Cyclic AMP Response Element-Binding Protein / metabolism*
  • Gene Expression Regulation*
  • Gluconeogenesis*
  • Glucose / metabolism
  • Glucose Clamp Technique
  • Hepatocytes / metabolism
  • Insulin / metabolism
  • Liver / metabolism*
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Mutation
  • Phosphorylation
  • Promoter Regions, Genetic
  • Transcription, Genetic*
  • p300-CBP Transcription Factors / metabolism*

Substances

  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • Insulin
  • p300-CBP Transcription Factors
  • Glucose